Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Why aren companies in industrialized countries developing a meningococcal vaccine that is appropriate for use in Africa?

April 26, 2017africa appropriate companies countries developing industrialized meningococcal vaccine

0

Posted

Why aren companies in industrialized countries developing a meningococcal vaccine that is appropriate for use in Africa?

1 Answer

0

Posted

Group A meningococcus is virtually nonexistent in industrialized countries, and returns on investment are perceived to be too low to commit substantial company resources to the development of vaccines for use mainly in Africa.